
Sign up to save your podcasts
Or
Latest Developments in the Treatment of Pulmonary Arterial Hypertension
Guest: Robert P. Frantz, M.D.
Host: Kyle Klarich, M.D.
Pulmonary arterial hypertension (PAH) is a serious disease manifested by vasoconstriction and obliteration of the pulmonary arterial vasculature resulting in rise in pulmonary artery pressure and resistance and culminating in right heart failure. Listeners will learn more about traditional treatments for PAH, as well as new anti-proliferative therapies in active clinical investigation, and what that means for the future of treatment.
Topics Discussed:
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
No CME credit offered for this episode.
Podcast episode transcript found here.
4.5
2828 ratings
Latest Developments in the Treatment of Pulmonary Arterial Hypertension
Guest: Robert P. Frantz, M.D.
Host: Kyle Klarich, M.D.
Pulmonary arterial hypertension (PAH) is a serious disease manifested by vasoconstriction and obliteration of the pulmonary arterial vasculature resulting in rise in pulmonary artery pressure and resistance and culminating in right heart failure. Listeners will learn more about traditional treatments for PAH, as well as new anti-proliferative therapies in active clinical investigation, and what that means for the future of treatment.
Topics Discussed:
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices.
LinkedIn: Mayo Clinic Cardiovascular Services
No CME credit offered for this episode.
Podcast episode transcript found here.
128 Listeners
315 Listeners
162 Listeners
850 Listeners
481 Listeners
282 Listeners
3,326 Listeners
137 Listeners
1,095 Listeners
51 Listeners
173 Listeners
510 Listeners
320 Listeners
413 Listeners
362 Listeners